首页|熟地锁阳方治疗特发性肺纤维化的回顾性临床研究

熟地锁阳方治疗特发性肺纤维化的回顾性临床研究

扫码查看
目的 评价熟地锁阳方治疗特发性肺纤维(IPF)的临床疗效,为该方的进一步开发和临床应用提供科学依据.方法 收集2018 年1 月—2022 年12 月就诊于首都医科大学附属北京中医医院呼吸科门诊且诊断为IPF的患者资料.根据患者用药情况分为对照组26 例和治疗组35例,对照组应用吡非尼酮口服治疗,治疗组应用熟地锁阳方加减治疗,2 组疗程均为3 个月.比较2组患者治疗前后的中医证候积分、莱斯特咳嗽生命质量问卷评分(LCQ)、肺功能、改良的医学研究委员会呼吸困难评分(mMRC)、咳嗽及呼吸困难的视觉模拟评分(VAS)、6 min步行距离(6MWD)、经皮血氧饱和度(SpO2).结果 与治疗前比较,治疗后2 组中医证候积分、mMRC评分、咳嗽及呼吸困难VAS评分均明显降低(P均<0.05),LCQ评分、用力肺活量占预计值百分比(FVC%)、一氧化碳弥散量占预计值百分比(DLco SB%)、肺活量占预计值百分比(VC MAX%)、6MWD及SpO2均明显增加(P均<0.05).与对照组比较,治疗后治疗组的中医证候积分、mMRC评分、咳嗽及呼吸困难VAS评分更低(P<0.05),LCQ评分更高(P<0.05),2 组FVC%、DLco SB%、VC MAX%、6MWD、SpO2 比较差异均无统计学意义(P均>0.05).治疗组临床总有效率为80.0%(28/35),对照组为76.9%(20/26),2 组比较差异无统计学意义(P>0.05).2 组患者血常规、肝肾功能均未见明显异常;对照组中3 例患者出现不良反应,治疗组未见明显不良反应.结论 熟地锁阳方是治疗IPF患者有效复方,可减轻患者咳嗽、呼吸困难等临床症状,改善其肺功能,提高患者活动耐力及增加机体携氧量.
Retrospective clinical study of Shudi Suoyang decoction in the treatment of idiopathic pulmonary fibrosis
Objective It is to evaluate the clinical curative effect of Shudi Suoyang decoction on Idiopathic pulmonary fibrosis(IPF),and to provide scientific evidences for the further development and clinical application of this decoction.Methods The data of patients diagnosed with IPF in the outpatient room of Respiratory Department of Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University from January 2018 to December 2022 were collected.The patients were divided into control group(n=26)and treatment group(n=35)according to their drug use.The con-trol group was treated with pirfenidone,and the treatment group was treated with modified Shudi Suoyang decoction,both groups were treated for 3 months.The scores of traditional Chinese medical syndrome,scores of Lester Cough Quality of Life Questionnaire(LCQ),lung function,mMRC scores,scores of visual analog scale(VAS)for cough and dyspnea,6-minute walking test(6MWT),and percutaneous oxygen saturation SpO2 of the patients in the two groups were compared before and after treatment.Results Compared with before treatment,traditional Chinese medical syndrome scores,mMRC scores,VAS scores of cough and dyspnea were significantly decreased after treatment(all P<0.05),wile the LCQ scores,FVC%,DLco SB%,VC MAX%,6MWD and SpO2 were significantly increased(all P<0.05).Compared with the con-trol group,the traditional Chinese medical syndrome scores,mMRC scores,VAS scores of cough and dyspnea in the treat-ment group were significantly lower while LCQ scores was significantly higher after treatment(all P<0.05),there were no significant differences in FVC%,DLco SB%,VC MAX%,6MWD,SpO2%between the two groups after treatment(all P>0.05).The total effective rate was 80.00%(28/35)in the treatment group and 76.92%(20/26)in the control group,and there was no significant difference between the two groups(P>0.05).There were no obvious abnormalities in blood routine,liver and kidney function in the two groups.Adverse reactions occurred in 3 cases of patients in the control group,while no obvious adverse reactions were observed in the treatment group.Conclusion Shudi Suoyang decoction is an effec-tive compound in the treatment of IPF patients.It can reduce the clinical symptoms of patients such as cough and dyspnea,improve their lung function and increase activity endurance and oxygen uptake.

idiopathic pulmonary fibrosisShudi Suoyang formulalung function

张宁、郭亚丽、刘建、彭艳茹、崔嘉树、王玉光

展开 >

北京中医医院顺义医院,北京 100010

首都医科大学附属北京中医医院,北京 100010

北京中医药大学,北京 100029

特发性肺纤维化 熟地锁阳方 肺功能

高层次公共卫生技术人才培养建设项目计划首都卫生发展科研专项项目

学科带头人-01-16首发2020-2-2233

2024

现代中西医结合杂志
中国中西医结合学会河北分会,中华中医药学会

现代中西医结合杂志

CSTPCD
影响因子:1.775
ISSN:1008-8849
年,卷(期):2024.33(16)